Filter by: patients
Home > Community Treatment Reports and Side Effects > Cladribine Treatment Report
What is Cladribine?

Cladribine is an antineoplastic agent used in the treatment of hairy cell leukemia. It is being used off-label in the treatment of chronic lymphocytic leukemia, chronic myelogenous leukemia, non-Hodgkin's lymphomas, progressive multiple sclerosis.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
MS (Multiple Sclerosis) 5 2 Efficacy_major Efficacy_none
Hairy cell leukemia 3 1 Efficacy_moderate
Improve mobility 1 0
Other 1 0
Don't know 1 0

See all 4 patients currently taking Cladribine

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 3

Reported Dosages

  daily 1 mg every 3 months 1 tab(s) daily 20 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Cladribine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 6   Course of treatment ended: 75%
Doctor's advice 3   Doctor's advice: 38%
Did not seem to work 1   Did not seem to work: 13%
Other 1   Other: 13%
Not indicated 1   Not indicated: 13%

See all 8 patients who’ve stopped taking Cladribine

Reported Duration See details about how long patients take this treatment ▼

Stopped Taking Cladribine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Cladribine

Always
 2 67%
Usually
 0 0%
Sometimes
 0 0%
Never
 1 33%

Burden

Difficulty being on treatment

Burden of Cladribine

Very
 0 0%
Somewhat
 1 33%
A little
 0 0%
Not at all
 2 67%

Cost

Paid out of pocket

Cost of Cladribine

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 3 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.